Delivery Order SPE2DB20D2001-SPE2DB25FPLKG

Award Date 11/1/24
Potential Completion Date 11/4/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Nayzilam 5 mg nasal sprays. The $4,451.02 firm fixed-price delivery order has an ultimate completion date of August 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the delivery of Nayzilam 5 mg nasal sprays. The contract has a ceiling value of $1,398.65 and an ultimate completion date of December 31, 2024. This appears to be a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,370.79, is for the delivery of Nayzilam 5 mg nasal sprays. It has a firm fixed-price pricing type and an ultimate completion date of December 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp for the delivery of 4,566,447,110 units of NAYZILAM 5 MG NASAL SPRAYS. The $1,194.74 firm fixed-price Delivery Order has a completion date of November 18, 2024 and is not designated under any set-aside program. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, with a ceiling value of $1,008.39, is a delivery order for 4,564,389,901 units of the pharmaceutical product NAYZILAM 5 MG NASAL SPRAYS. The contract has no set-aside designation and is a firm fixed-price arrangement with an ultimate completion date of April 25, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NAYZILAM 5 MG NASAL SPRAYS, a pharmaceutical product, under a Firm Fixed Price contract valued at $1,149.50. The contract has an ultimate completion date of October 18, 2024 and was awarded on October 17, 2024. This appears to be a delivery order under a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,307.28 firm fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,430.74 firm fixed-price delivery order is for the supply of Nayzilam 5 mg nasal sprays, with an ultimate completion date of February 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of NAYZILAM 5 MG NASAL SPRAYS. The $3,759.12 firm fixed-price delivery order has a completion date of December 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of NAYZILAM 5 MG NASAL SPRAYS. The contract has a ceiling value of $1,344.52 and is a firm fixed-price delivery order with a final completion date of November 8, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB25FPLKG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nayzilam 5 mg nasal sprays. The contract has a firm fixed price, with a ceiling value of $1,344.52 and a performance period through November 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities across multiple therapeutic domains.

Generated 2/27/25, 11:01 AM